These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11251656)

  • 1. Unexpected bleeding disorders: Algorithm for approach to therapy.
    Teitel JM
    Clin Lab Haematol; 2000 Oct; 22 Suppl 1():26-9; discussion 30-2. PubMed ID: 11251656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin--a haemostatic drug: state-of-the-art review.
    Lethagen S
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():1-9. PubMed ID: 9088828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous inhibitors to coagulation factors.
    Green D
    Clin Lab Haematol; 2000 Oct; 22 Suppl 1():21-5; discussion 30-2. PubMed ID: 11251655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of von Willebrand's disease.
    Aledort LM
    Mayo Clin Proc; 1991 Aug; 66(8):841-6. PubMed ID: 1907343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern coagulation management reduces the transfusion rate of allogenic blood products].
    Weber CF
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Jun; 47(6):418-24; quiz 425. PubMed ID: 22744856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An inherited hemostatic disorder as the cause of menorrhagia].
    Leebeek FW; Lotgering FK
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):545-8. PubMed ID: 11938574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protocol for the dental management of von Willebrand's disease, haemophilia A and haemophilia B.
    Stubbs M; Lloyd J
    Aust Dent J; 2001 Mar; 46(1):37-40. PubMed ID: 11355239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin.
    Czer LS; Bateman TM; Gray RJ; Raymond M; Stewart ME; Lee S; Goldfinger D; Chaux A; Matloff JM
    J Am Coll Cardiol; 1987 May; 9(5):1139-47. PubMed ID: 3571753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of haemostatic drugs in haemophilia: desmopressin and antifibrinolytic agents.
    Villar A; Jimenez-Yuste V; Quintana M; Hernandez-Navarro F
    Haemophilia; 2002 May; 8(3):189-93. PubMed ID: 12010409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin and bleeding during invasive surgery.
    Hunt BJ
    Eur J Anaesthesiol Suppl; 1997 Mar; 14():42-7; discussion 47-9. PubMed ID: 9088835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surreptitious bleeding in surgery: a major challenge in coagulation.
    Rice L
    Clin Lab Haematol; 2000 Oct; 22 Suppl 1():17-20; discussion 30-2. PubMed ID: 11251654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of bleeding complications of hematologic malignancies.
    Green D
    Semin Thromb Hemost; 2007 Jun; 33(4):427-34. PubMed ID: 17525900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
    Lethagen S
    Semin Thromb Hemost; 2003 Feb; 29(1):101-6. PubMed ID: 12640572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin treatment improves platelet function under flow in patients with postoperative bleeding.
    Swieringa F; Lancé MD; Fuchs B; Feijge MA; Solecka BA; Verheijen LP; Hughes KR; van Oerle R; Deckmyn H; Kannicht C; Heemskerk JW; van der Meijden PE
    J Thromb Haemost; 2015 Aug; 13(8):1503-13. PubMed ID: 25988848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
    Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
    Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.